findmyKOL
Clinical trialNCT04565756CompletedPhase 1/PHASE2Interventional

A Study to Evaluate the Safety and Tolerability of EXN407

SponsorExonate LimitedEnrollment48Diabetic Macular Edema
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Macquarie University

    Macquarie, New South Wales, Australia

  • Marsden Eye Specialists

    Parramatta, New South Wales, Australia

  • Strathfield Retina Clinic

    Sydney, New South Wales, Australia

  • Sydney Eye Hospital/save Sight Institution

    Sydney, New South Wales, Australia

  • Newcastle Eye Hospital Foundation

    Waratah, New South Wales, Australia

  • Princess Alexandra Hospital

    Woolloongabba, Queensland, Australia

  • Adelaide Eye and Retina Centre

    Adelaide, South Australia, Australia

  • Centre for Eye Research Australia (cera)

    Melbourne, Victoria, Australia

  • Retinology Institute

    Melbourne, Victoria, Australia

  • Lions Eye Institute

    Nedlands, Western Australia, Australia

  • Sydney Retina Clinic & Day Surgery

    Sydney, Australia

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
5 Nov 2020
Primary completion
25 Oct 2022
Completion
29 Nov 2022
Last update posted
9 May 2025
Registered enrollment
48
Registry id
NCT04565756

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.